- Report
- June 2023
- 150 Pages
Global
From €4557EUR$4,850USD£3,801GBP
- Report
- May 2023
- 150 Pages
Global
From €4557EUR$4,850USD£3,801GBP
- Report
- May 2023
- 150 Pages
Global
From €4557EUR$4,850USD£3,801GBP
- Report
- April 2023
- 150 Pages
Global
From €4557EUR$4,850USD£3,801GBP
- Report
- April 2023
- 150 Pages
Global
From €4557EUR$4,850USD£3,801GBP
- Report
- April 2023
- 150 Pages
Global
From €4557EUR$4,850USD£3,801GBP
- Report
- May 2024
- 40 Pages
Global
From €653EUR$695USD£545GBP
- Training
- October 2025
- 2 Days
Global
From €1573EUR$1,674USD£1,312GBP
- Training
- December 2027
- 3 Hours
Global
€434EUR$478USD£350GBP
€496EUR$547USD£400GBP
- Training
- November 2027
- 3 Hours
Global
€434EUR$478USD£350GBP
€496EUR$547USD£400GBP
- Training
- October 2027
- 3 Hours
China
€434EUR$478USD£350GBP
€496EUR$547USD£400GBP
- Training
- September 2027
- 2 Days
Russia
€1612EUR$1,776USD£1,299GBP
€1860EUR$2,049USD£1,499GBP
- Training
- June 2027
- 3 Hours
Global
€434EUR$478USD£350GBP
€496EUR$547USD£400GBP
- Training
- May 2027
- 3 Hours
Global
€434EUR$478USD£350GBP
€496EUR$547USD£400GBP
- Training
- April 2027
- 3 Hours
China
€434EUR$478USD£350GBP
€496EUR$547USD£400GBP
- Training
- March 2027
- 2 Days
Russia
€1612EUR$1,776USD£1,299GBP
€1860EUR$2,049USD£1,499GBP
- Training
- December 2026
- 3 Hours
Global
- Training
- November 2026
- 3 Hours
Global
- Report
- November 2025
- 140 Pages
Global
From €4557EUR$4,850USD£3,801GBP
- Report
- October 2025
- 83 Pages
Global
From €4228EUR$4,500USD£3,526GBP

The Contract Research Organization (CRO) market within the biotechnology sector is a rapidly growing industry. It provides services to biotechnology companies, such as drug discovery, preclinical and clinical trials, and regulatory affairs. CROs are often used to outsource research and development activities, allowing biotechnology companies to focus on their core competencies. CROs also provide access to specialized expertise and resources, such as specialized laboratory equipment and personnel.
CROs are increasingly being used to reduce costs and speed up the development process. They are also used to reduce the risk associated with drug development, as they can provide access to a wide range of expertise and resources.
Some of the major companies in the CRO market include Parexel, Quintiles, Charles River Laboratories, Covance, and PRA Health Sciences. Show Less Read more